The Impact of Cholecystectomy in Patients with Post-Bariatric Surgery Hypoglycemia

Daniel Sardão,Hugo Santos-Sousa,Bárbara Peleteiro,Fernando Resende,André Costa-Pinho,John Preto,Eduardo Lima-da-Costa,Paula Freitas,CRI-O Group
DOI: https://doi.org/10.1007/s11695-024-07325-y
2024-06-07
Obesity Surgery
Abstract:Metabolic surgery is the foremost treatment for obesity and its associated medical conditions. Nonetheless, post-bariatric hypoglycemia (PBH) emerges as a prevalent complication. PBH pathophysiology implicates heightened insulin and glucagon-like peptide 1 (GLP-1) levels, with bile acids (BA) contributing to GLP-1 release. A plausible association exists between cholecystectomy and PBH, which is attributed to alterations in BA metabolism and ensuing hormonal responses. The objective of this retrospective cohort study was to evaluate the impact of cholecystectomy on PBH pharmacological treatment, diagnostic timelines and metabolic parameters.
surgery
What problem does this paper attempt to address?